Asarina Pharma: First Patients Begin Phase IIB Trials of World's First-ever Therapy Developed Specifically to Treat PMDD

STOCKHOLM, April 27, 2018 /PRNewswire/ -- The first patients arrived in clinics in Krakow, Poland and Berlin, Germany to take part in Phase IIB trials of the world's first treatment for PMDD. CEO Peter Nordkild: "This is a milestone moment. Already having patients in the clinic, only ten...

from PR Newswire: //https://ift.tt/2r4ZjJc